Licht AH, Muller-Holtkamp F, Flamme I, Breier G:
Inhibition of hypoxia-inducible factor activity in
endothelial cells disrupts embryonic cardiovascular
development. Blood 107: 584-90, 2006
Mitola S, Brenchio B, Piccinini M, Tertoolen L,
Zammataro L, Breier G, Rinaudo MT, den Hertog J,
Arese M, Bussolino F: Type I Collagen limits VEGFR-2
signaling by a SHP2 protein-tyrosine
phosphatase-dependent mechanism. Circ Res 98:
45-54, 2006
Rajashekhar G, Willuweit A, Patterson CE, Sun P, Hilbig
A, Breier G, Helisch A, Clauss M: Continuous
endothelial cell activation increases angiogenesis:
evidence for the direct role of endothelium linking
angiogenesis and inflammation. J Vasc Res 43:
193-204, 2006
Breier G: Lymphangiogenesis in regenerating
tissue: is VEGF-C sufficient? Circ Res 96:
1132-34, 2005
Lai Y, Schneider D, Kidszun A, Hauck-Schmalenberger I, Breier G, Branshorst D, Branshorst H, Iken M,
Brendel MD, Bretzel RG, Linn T: Vascular endothelial
growth factor increases functional beta-cell mass by
improvement of angiogenesis of isolated human and murine
pancreatic islets. Transplantation 79:
1530-36, 2005
Masson V, Rodriguez de la Ballina L, Munaut C, Wielockx
B, Jost M, Maillard C, Blacher S, Bajou K, Itoh T, Werb
Z, Libert C, Foidart J-M and Noël A: Impaired malignant
keratinocyte invasion and tumoral vascularization in
double MMP2 and MMP9 knock out mice. FASEB J 19: 234-36, 2005
Van Lint P, Wielockx B, Lopez-Otin C, Noel A, and Libert
C: MMP8-deficiency leads to reduced development of
hepatitis due to reduced LIX cleavage. J Immunol 175: 7642-49, 2005
Wullaert A, Wielockx B, Van Huffel S, Bogaert V, De
Geest B, Papeleu P, El Bakkouri K, Heyninck K, Libert C,
and Beyaert R: Adenoviral gene transfer of ABIN-1
protects mice from TNF/Galactosamine-induced acute liver
failure and lethality. Hepatology 42:
381-89, 2005
Clauss M, Breier G, eds.: "Mechanisms of
Angiogenesis". Birkhäuser Verlag Basel, 2004
Hammes HP, Lin J, Wagner P, Feng Y, vom Hagen F, Krzizok
T, Renner O, Breier G, Brownlee M, Deutsch U:
Angiopoietin-2 causes pericyte dropout in the normal
retina. Evidence for involvement in diabetic
retinopathy. Diabetes 53: 1104-10, 2004
Heidenreich R, Machein M, Nicolaus A, Hilbig A, Wild C,
Clauss M, Plate KH, Breier G: Inhibition of solid
tumor growth by gene transfer of dominant-negative VEGF
receptor-1 mutants. Int J Cancer 111: 348-57,
2004
Licht AH, Hofmann U, Raab S, Breier G:
Endothelium-specific Cre recombinase activity in
flk-1-Cre transgenic mice. Dev Dyn 229:
312-18, 2004
Raab S, Beck H, Gaumann A, Yuce A, Gerber HP, Plate KH,
Hammes HP, Ferrara N, Breier G: Impaired brain
angiogenesis and neuronal apoptosis induced by
conditional homozygous inactivation of vascular
endothelial growth factor. Thromb Haemost 91:
595-605, 2004
Augustin HG, Breier G: Angiogenesis: molecular
mechanisms and functional interactions. 2nd Kloster
Seeon Meeting of the German Priority Research Grant "Angiogenesis"
(SPP1069). Thromb Haemost 89: 190-97, 2003
Elvert G, Kappel A, Heidenreich R, Englmeier U, Lanz S,
Acker T, Rauter M, Plate KH, Siewecke M, Breier G,
Flamme I: Cooperative interaction of hypoxia-inducible
factor-2a and Ets-1 in the transcriptional activation of
Flk-1. J Biol Chem 278: 7520-30, 2003
Hirai H, Ogawa M, Suzuki N, Yamamoto M, Breier G,
Mazda O, Imanishi J, Nishikawa SI (). Hemogenic and
non-hemogenic endothelium can be distinguished by the
activity of fetal liver kinase (Flk)-1 promoter/enhancer
during mouse embryogenesis. Blood 101:
886-93, 2003
Issbrücker K, Marti HH, Hippenstiel S, Springmann G,
Vosswinkel R, Gaumann A, Breier G, Drexler HCA,
Suttorp N, Clauss M: p38 MAPK - a molecular switch
between angiogenesis and vascular permeability. FASEB
J 17: 262-264, 2003
Voswinckel R, Ziegelhoeffer T, Heil M, Kostin S, Breier G, Mehling T, Schaper W, Seeger W: Bone
marrow derived cells do not contribute to compensatory
lung growth. Circ Res 93: 372-9, 2003
|
Georg.Breier(at)uniklinikum-dresden.de 